Congratulations to Golden Seeds company RenovoRX on the pricing of its IPO on August 25th. RenovoRx an innovative biopharmaceutical company headquartered in Silicon Valley, California, that has developed a therapy platform to deliver chemotherapy, to difficult-to-treat tumors.
The RenovoTAMP therapy is being studied in the Phase III TIGeR-PaC trial for the treatment of locally advanced pancreatic cancer. Kudos to CEO Shaun Bagai and the entire RenovoRX team, including Managing Director of Golden Seeds and RenovoRx board member Una Ryan.
